About LENSAR, Inc.
https://www.lensar.comLENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
CEO
Nicholas T. Curtis
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 43
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NORTH RUN CAPITAL, LP
Shares:1.1M
Value:$13.01M
BRANDES INVESTMENT PARTNERS, LP
Shares:777.7K
Value:$9.23M
BLACKROCK, INC.
Shares:624.22K
Value:$7.41M
Summary
Showing Top 3 of 90
About LENSAR, Inc.
https://www.lensar.comLENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $14.32M ▲ | $13.39M ▲ | $-3.71M ▼ | -25.94% ▼ | $-0.31 ▼ | $-2.56M ▲ |
| Q2-2025 | $13.94M ▼ | $13.31M ▲ | $-1.76M ▲ | -12.66% ▲ | $-0.15 ▲ | $-5.19M ▼ |
| Q1-2025 | $14.16M ▼ | $12.91M ▲ | $-27.34M ▼ | -193.13% ▼ | $-2.32 ▼ | $-4.71M ▼ |
| Q4-2024 | $16.73M ▲ | $8.4M ▲ | $-18.7M ▼ | -111.78% ▼ | $-1.61 ▼ | $-184K ▲ |
| Q3-2024 | $13.54M | $7.28M | $-1.5M | -11.09% | $-0.13 | $-239K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $16.87M ▼ | $70.2M ▼ | $82.33M ▲ | $-12.12M ▼ |
| Q2-2025 | $20.31M ▼ | $70.41M ▼ | $79.68M ▼ | $-9.27M ▲ |
| Q1-2025 | $25.25M ▲ | $72.96M ▲ | $95.1M ▲ | $-22.14M ▼ |
| Q4-2024 | $22.45M ▲ | $66.3M ▲ | $61.44M ▲ | $4.86M ▼ |
| Q3-2024 | $18.08M | $62.02M | $39.28M | $22.74M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.71M ▼ | $-3.51M ▲ | $4M ▲ | $0 ▼ | $487K ▲ | $-3.51M ▲ |
| Q2-2025 | $-1.76M ▲ | $-5M ▲ | $-7.49M ▼ | $93K ▼ | $-12.4M ▼ | $-5.08M ▲ |
| Q1-2025 | $-27.34M ▼ | $-6.94M ▼ | $531K ▼ | $9.69M ▲ | $3.28M ▼ | $-6.94M ▼ |
| Q4-2024 | $-18.7M ▼ | $3.66M ▲ | $1.99M ▲ | $172K ▲ | $5.82M ▲ | $3.65M ▲ |
| Q3-2024 | $-1.5M | $3.15M | $-905K | $-93K | $2.15M | $3.13M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
 Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 Asia Excluding South Korea | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Europe | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
 KOREA REPUBLIC OF | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Other Geographical Region | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $20.00M ▲ | $10.00M ▼ | $10.00M ▲ | $10.00M ▲ |
CEO
Nicholas T. Curtis
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 43
Ratings Snapshot
Rating : C
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
NORTH RUN CAPITAL, LP
Shares:1.1M
Value:$13.01M
BRANDES INVESTMENT PARTNERS, LP
Shares:777.7K
Value:$9.23M
BLACKROCK, INC.
Shares:624.22K
Value:$7.41M
Summary
Showing Top 3 of 90